An Unusual Case of Orf with Erythema Multiforme and Vesiculo-bullous Lesions after Eid al-Adha

An Unusual Case of Orf with Erythema Multiforme and Vesiculo-bullous Lesions after Eid al-Adha

Bibliographic Details
Main Authors:	Serpil EROL, Çiğdem AKALAN KUYUMCU, Seniha ŞENBAYRAK, Mert Ahmet KUŞKUCU, Kenan MİDİLLİ, Sema AYTEKİN, Pembegül GÜNEŞ
Format:	Article
Language:	Turkish
Published:	Galenos Yayinevi 2019-12-01
Series:	Mediterranean Journal of Infection, Microbes and Antimicrobials
Subjects:	echthyma contagiosa piperacillin tazobactam contagious pustular dematitis autoinoculation nested polymerase chain reaction
Online Access:	http://mjima.org/text.php?&id=177

Similar Items

Mechanisms of Piperacillin/Tazobactam Nephrotoxicity: Piperacillin/Tazobactam-Induced Direct Tubular Damage in Mice
by: Jihyun Yang, et al.
Published: (2023-06-01)

Is Piperacillin-Tazobactam an Appropriate Empirical Agent for Hospital-Acquired Sepsis and Community-Acquired Septic Shock of Unknown Origin in Australia?
by: Alice Gage-Brown, et al.
Published: (2022-05-01)

Similar Piperacillin/Tazobactam Target Attainment in Obese versus Nonobese Patients despite Differences in Interstitial Tissue Fluid Pharmacokinetics
by: David Busse, et al.
Published: (2021-08-01)

Piperacillin/Tazobactam-Induced Neutropenia: A Case Report
by: Hayati DEMİRASLAN, et al.
Published: (2012-03-01)

Lowered Risk of Nephrotoxicity through Intervention against the Combined Use of Vancomycin and Tazobactam/Piperacillin: A Retrospective Cohort Study
by: Kazutaka Oda, et al.
Published: (2021-09-01)

TWO MEDICALLY IMPORTANT BEETLES OF FARS PROVINCE (IRAN): PAEDERUS SPP. (COL: STAPHYLINIDAE) & ITS LINEAR DERMATITLS
by: MR. Nikbakhtzadeh, et al.
Published: (1999-12-01)

Impact of extended-infusion piperacillin-tazobactam in a Canadian community hospital
by: April J. Chan, et al.
Published: (2023-03-01)

Susceptive piperacillin-tazobactam-induced Evans syndrome after radical resection of esophageal cancer: A rare case report
by: Yan Li, et al.
Published: (2023-12-01)

Comparison of Piperacillin and Tazobactam Pharmacokinetics in Critically Ill Patients with Trauma or with Burn
by: Daniel J. Selig, et al.
Published: (2022-05-01)

Simple HPLC-UV Method for Piperacillin/Tazobactam Assay in Human Plasma
by: Khaled Abdelkawy, et al.
Published: (2023-02-01)

The effect of meropenem versus piperacillin-tazobactam in critically ill patients with sepsis and septic shock
by: Yang Sun, et al.
Published: (2023-06-01)

Rapid onset severe thrombocytopenia following reexposure to piperacillin-tazobactam: report of two cases and review of the literature
by: Musa Alzahrani, et al.
Published: (2018-08-01)

A Case of DRESS Syndrome Associated with Piperacillin-Tazobactam Treatment and Literature Review
by: Seven ULUDOKUMACI, et al.
Published: (2012-12-01)

Galactomannan detection from piperacillin-tazobactam brands available in the Brazilian market
by: Melissa Orzechowski Xavier, et al.

Real-life comparison of three intravitreal antibiotic drug regimens in endophthalmitis
by: Aafreen Bari, et al.
Published: (2022-01-01)

Risk Factors of Death in Bloodstream Infections Caused by AmpC β-Lactamase-Producing Enterobacterales in Patients with Neoplasia
by: Cunha Ferreira T, et al.
Published: (2021-08-01)

Analysis of antibiotics discontinuation during bone marrow suppression in childhood, adolescent and young adult patients with febrile neutropenia
by: Ryoji Kobayashi, et al.
Published: (2021-12-01)

Piperacillin/Tazobactam Co-Delivery by Micellar Ionic Conjugate Systems Carrying Pharmaceutical Anions and Encapsulated Drug
by: Katarzyna Niesyto, et al.
Published: (2024-01-01)

Steady-State Piperacillin Concentrations in the Proximity of an Orthopedic Implant: A Microdialysis Porcine Study
by: Johanne Gade Lilleøre, et al.
Published: (2023-03-01)

Diminished Susceptibility to Cefoperazone/Sulbactam and Piperacillin/Tazobactam in Enterobacteriaceae Due to Narrow-Spectrum β-Lactamases as Well as Omp Mutation
by: Yang Fengzhen, et al.
Published: (2022-06-01)

First UK case report of a patient with Pseudomonas mendocina bacteraemia
by: Natasha Greenough, et al.
Published: (2021-04-01)

Fosfomycin Resistance in <i>Escherichia coli</i> Isolates from South Korea and <i>in vitro</i> Activity of Fosfomycin Alone and in Combination with Other Antibiotics
by: Hyeri Seok, et al.
Published: (2020-03-01)

Comparison of risk of acute kidney injury between patients receiving the combination of teicoplanin and piperacillin/tazobactam versus vancomycin and piperacillin/tazobactam
by: Chi-Hao Shao, et al.
Published: (2022-01-01)

A therapeutic trial comparing modified autoinoculation, a novel approach with topical potassium hydroxide application in the treatment of molluscum contagiosum
by: Akshay Samagani, et al.
Published: (2022-01-01)

Antibiotic prophylaxis with piperacillin–tazobactam reduces organ/space surgical site infection after pancreaticoduodenectomy: a retrospective and propensity score-matched analysis
by: Yifei Yang, et al.
Published: (2024-02-01)

Comparative Risk of Acute Kidney Injury Following Concurrent Administration of Vancomycin with Piperacillin/Tazobactam or Meropenem: A Systematic Review and Meta-Analysis of Observational Studies
by: Abdulmajeed M. Alshehri, et al.
Published: (2022-04-01)

Piperacillin–Tazobactam Plus Vancomycin-Associated Acute Kidney Injury in Adults: Can Teicoplanin or Other Antipseudomonal Beta-Lactams Be Remedies?
by: Abdullah Tarık Aslan, et al.
Published: (2022-08-01)

Incidence and Determinants of Piperacillin/Tazobactam-Associated Hypokalemia: A Retrospective Study
by: Heenam Seo, et al.
Published: (2022-08-01)

Design of an Experimental Study for the Simultaneous Determination of Cefepime, Piperacillin and Tazobactam Using Micellar Organic Solvent-Free HPLC
by: Hani M. Hafez, et al.
Published: (2022-08-01)

Pathogen-based target attainment of optimized continuous infusion dosing regimens of piperacillin-tazobactam and meropenem in surgical ICU patients: a prospective single center observational study
by: Thomas De Corte, et al.
Published: (2023-04-01)

A case of bloodstream infection caused by Ruminococcus gnavus without gastrointestinal involvement
by: Tomoki Furutani, et al.
Published: (2023-05-01)

Use of cefepime, meropenem, or piperacillin/tazobactam as initial treatment for febrile neutropenia in patients with hematological malignancy — a real-life experience
by: Najmul Karim, et al.
Published: (2022-08-01)

Examining the Clinical Effectiveness of Non-Carbapenem β-Lactams for the Treatment of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae
by: Allison M. Gibble, et al.
Published: (2015-12-01)

Comparison of the Treatment Outcome of Piperacillin-Tazobactam versus Carbapenems for Patients with Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli in Areas with Low Frequency of Coproduction of OXA-1: a Preliminary Analysis
by: Kosuke Hoashi, et al.
Published: (2022-08-01)

Urinary Metabolites of Green Tea as Potential Markers of Colonization Resistance to Pathogenic Gut Bacteria in Mice
by: Mark E. Obrenovich, et al.
Published: (2014-11-01)

Synthesis and evaluation of polymeric micelle containing piperacillin/tazobactam for enhanced antibacterial activity
by: Milani Morteza, et al.
Published: (2019-01-01)

Superinfection rate among the patients treated with carbapenem versus piperacillin/tazobactam: Retrospective observational study
by: Hessa Al Muqati, et al.
Published: (2021-03-01)

Evaluation of Piperacillin/Tazobactam Use and Resistance Pattern in a Teaching Hospital, Northwest Iran
by: Afshin Shiva, et al.
Published: (2022-06-01)

A meta-analysis of piperacillin/tazobactam versus cefepime treatment in cancer patients with febrile neutropenia
by: Zhang Weidong, et al.
Published: (2016-12-01)

Risk factors of nosocomial infections caused by piperacillin-tazobactam resistant Pseudomonas aeruginosa
by: Đorđević Zorana, et al.
Published: (2013-01-01)